We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neurones | EU:NRO | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 0.89% | 45.40 | 45.05 | 45.40 | 45.40 | 44.75 | 45.00 | 15,153 | 16:35:02 |
PRESS INFORMATION Nanterre, February 27, 2013 (after the closing of the stock exchange)
Heading: 2012 annual results
8.9% operating profit and
€17.2 million net profit in 2012
Accounts as at 31 December (audited and in millions of euros) | 2012 | 2011 |
Revenues | 315.4 | 283.3 |
Business operating profit * | 29.2 (9.3%) | 27.1 (9.6%) |
Operating profit | 28.1 (8.9%) | 26.3 (9.3%) |
Net financial profit | 1.4 | 2.5 |
Income tax | (12.3) | (11.8) |
Net profit | 17.2 (5.4%) | 17.0 (6.0%) |
| 14.9 | 14.8 |
Net cash and cash equivalents | 87.8 | 75.1 |
Staff at year-end | 3,704 | 3,471 |
(*) Prior to cost of free shares, stock options and impairment of assets
Achievements
In a steady market, NEURONES experienced growth of 11.3% in 2012 (including 9.3% internal growth).
Operating profit (*) in 2012 also increased and totaled 8.9% of revenues.
The net profit after tax (rate of 41.7%, including CVAE, a contribution based on businesses' added value) amounted to 5.4%.
The conversion of net profit into cash was satisfactory. The net cash and cash equivalents at year-end stood at €87.8 million (i.e. €3.71 per share).
Goodwill only represents three years of the acquired companies' cash flow overall.
(*) after 0.4% related to the cost of free shares, stock options and impairment of assets.
Outlook
As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues.
About NEURONES
With over 3,700 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems. The size of the group has doubled over the past five years.
NYSE Euronext: Compartment B - ISIN code: FR0004050250 - NYSE symbol: NRO
www.neurones.net
Press Relations: Florence Gillier Communication Frédérique Guillo Tel.: +33 (0)1 41 18 85 55 fredg@fgcom.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
1 Year Neurones Chart |
1 Month Neurones Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions